Related Experiment Video

Updated: May 23, 2026

Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor (CAR) T Cell Infusions in Mice
05:22

Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor (CAR) T Cell Infusions in Mice

Published on: February 24, 2023

Promises and challenges of exhausting pediatric neural cancer stem cells

Pedro Castelo-Branco1, Uri Tabori

  • 1Division of Haematology/Oncology, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.

Pediatric Research
|March 21, 2012
PubMed

Insights

Pediatric cancer stem cells (CSCs) drive tumor recurrence and resist therapy. Targeting these cells specifically, while sparing normal stem cells, is crucial for developing effective pediatric neuro-oncology treatments.

Area of Science:

  • Pediatric Oncology
  • Neuro-oncology
  • Cancer Stem Cell Biology

Background:

  • Cancer relapse is a significant challenge in pediatric oncology, with cancer stem cells (CSCs) identified as key drivers of tumor recurrence.
  • CSCs are a rare cell population with tumor-regenerating capabilities and inherent resistance to conventional cancer therapies.
  • Current CSC-directed therapies face challenges due to shared characteristics with normal stem cells, risking detrimental effects on tissue maintenance and development.

Purpose of the Study:

  • To review the promises and challenges of developing therapies specifically targeting pediatric neural CSCs.
  • To explore strategies for differentiating neural CSCs from normal neural stem cells for targeted treatment.
  • To outline current therapeutic options aimed at depleting the self-renewal capacity of neural CSCs.

Main Methods:

  • Review of current literature on pediatric neural CSCs and their therapeutic targeting.
  • Analysis of strategies for identifying and characterizing neural CSCs and distinguishing them from normal neural stem cells.
  • Evaluation of existing and potential therapeutic approaches for pediatric neural CSCs.

Main Results:

  • Advances in identifying and characterizing neural CSCs have improved the development of tailored therapeutics.
  • Understanding the differences between CSCs and normal neural stem cells is critical for designing safe and effective treatments.
  • No CSC-specific therapy is currently FDA-approved, highlighting the need for further research and development.

Conclusions:

  • Developing treatments that specifically target pediatric neural CSCs while preserving normal neural stem cell function is a major challenge.
  • A comprehensive approach combining anti-CSC therapies with other treatment modalities is essential to prevent tumor recurrence.
  • Further research into the unique biology of neural CSCs is vital for advancing pediatric neuro-oncology treatments.

More Related Videos

Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device07:44

Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device

Published on: May 2, 2025

Targeted and Selective Treatment of Pluripotent Stem Cell-derived Teratomas Using External Beam Radiation in a Small-animal Model05:08

Targeted and Selective Treatment of Pluripotent Stem Cell-derived Teratomas Using External Beam Radiation in a Small-animal Model

Published on: February 17, 2019

Related Concept Videos

Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...